If you liked this article you might like

Novartis, Amgen Divvy Global Marketing of New Migraine Drug
Home Depot, Federal Realty, more: 'Mad Money' Lightning Round
Amgen Shares Skyrocket on Surprise Patent Victory, Plus Jim Cramer's View
Allergan's Boldness may not be Limited to Tobira Deal